申请人:BEECHAM GROUP PLC
公开号:EP0077607A1
公开(公告)日:1983-04-27
Compounds of the formula (I), and pharmaceutically acceptable salts thereof:
wherein:
R, is hydroxy, C1-4 alkoxy or an in-vivo hydrolysable acyloxy group:
R2 is hydrogen, C1-4 alkyl, hydroxy, C1-4 alkoxy or an in-vivo hydrolysable acyloxy group;
R4 is benzofuryl, benzothienyl, indolyl, quinolyl, isoquinolyl,2,3-dihydrobenzofuryl, 2,3-dihydrobenzylthienyl or 2,3-dihydroindolyl optionally substituted by one or two substituents selected from C1-4 alkoxy, hydroxy or acyloxy, trifluoromethyl, halogen or nitro; and
A is a bond or C1-6 alkylene,
a process for their preparation, and pharmaceutical compositions containing them.
式 (I) 的化合物及其药学上可接受的盐类:
其中
R,是羟基、C1-4 烷氧基或体内可水解的酰氧基:
R2 是氢、C1-4 烷基、羟基、C1-4 烷氧基或体内可水解的酰氧基;
R4 是苯并呋喃基、苯并噻吩基、吲哚基、喹啉基、异喹啉基、2,3-二氢苯并呋喃基、2,3-二氢苄基噻吩基或 2,3-二氢吲哚基,可任选被选自 C1-4 烷氧基、羟基或酰氧基、三氟甲基、卤素或硝基的一个或两个取代基取代;以及
A 是键或 C1-6 烷基、
它们的制备方法,以及含有它们的药物组合物。